Organization Overview
Historical Acquisition Tree
Alternative names
aprepitant (Emend) (2019)
busulfan (Myleran) (2018)
melphalan (alkeran) (2019)
sevelamer (renagel) (2018)
Key: Salarius Pharmaceuticals, LLC (0) Acquired (2)
Carcinoma, Endometrioid (Phase 1)
Endometrial Neoplasms (Phase 1)
Neoplasms (Phase 1)
Sarcoma (Phase 1)
Sarcoma, Ewing (Phase 1)